Abstract
Studies initiated to investigate the expression of cytochrome P450 2E1 (CYP2E1) in rat brain demonstrated low but detectable protein and mRNA expression in control rat brain. Though mRNA and protein expression of CYP2E1 in brain was several fold lower as compared to liver, relatively high activity of N-nitrosodimethylamine demethylase (NDMA-d) was observed in control rat brain microsomes. Like liver, pretreatment with CYP2E1 inducers such as ethanol or pyrazole or acetone significantly increased the activity of brain microsomal NDMA-d. Kinetic studies also showed an increase in the Vmax and affinity (Km) of the substrate towards the brain enzyme due to increased expression of CYP2E1 in microsomes of brain isolated from ethanol pretreated rats. In vitrostudies using organic inhibitors, specific for CYP2E1 and anti-CYP2E1 significantly inhibited the brain NDMA-d activity indicating that like liver, NDMA-d activity in rat brain is catalyzed by CYP2E1. Olfactory lobes exhibited the highest CYP2E1 expression and catalytic activity in control rats. Furthermore, several fold increase in the mRNA expression and activity of CYP2E1 in cerebellum and hippocampus while a relatively small increase in the olfactory lobes and no significant change in other brain regions following ethanol pretreatment have indicated that CYP2E1 induction maybe involved in selective sensitivity of these brain areas to ethanol induced free radical damage and neuronal degeneration.
Similar content being viewed by others
References
Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Molecular characterization of the common human deficiency in metabolism of debrisoquine and other drugs. Nature 331:442–446, 1990
Guengerich FP, Shimada T: Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol 4: 391–407,1991
Murray GI, Burke MD: Immunohistochemistry of drug—metabolizingenzymes. Biochem, Pharm 50: 895–903, 1995
Philpot RM: Characterization of cytochrome P450 in extrahepatic tissues. Methods in Enzymology 206: 623–31, 1991
Das M, Seth PK, Mukhtar H: Characterization of microsomal aryl hydrocarbon hydroxylase of rat brain. Pharmacol J, Exp. Ther. 216: 156–161,1981
Dhawan A, Parmar D, Dayal M, Seth PK: Cytochrome P450 (P450)isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes. Mol. Cell. Biochem 200: 169–176, 1999
Parmar D, Dhawan A, Seth, PK: Evidence for dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain. Mol.Cell. Biochem 189: 201–205, 1998a
Parmar D, Dhawan A, Seth PK: Immunochemical evidence for the presence of Phenobarbital (PB) and 3-methylcholanthrene (MC) inducible cytochromeP450 isoenzymes in rat brain. Int J, Toxicol. 17: 619–630, 1998b
Ravindranath, Anandatheerthavarada HK: High activity of cytochrome P—450 linked aminopyrene N-demethylase in mouse brain microsomes andassociated sex related differences. Biochem J 261: 769–773, 1989
Strobel HW, Kawashima H, Geng J, Sequeira D, Bergh A, Hodgson AV, Wang H, Shen S: Expression of multiple forms of brain cytochrome P450. Toxicology Letters 82–83: 639–643, 1995
Lieber CS: Cytochrome P4502E1: its physiological, pathological role.Physiol. Rev. 77: 517–544, 1997
Raucy JL: Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP 2E1, Toxicology 105: 217–223, 1995
Ekstorm G, Ingelman—Sundberg M: Rat liver Microsomal NADPH supported oxidase activity and lipid peroxidation dependent on ethanol—induciblecytochrome P450. Biochem, Pharmacol 38: 1313–1319, 1989
Okhuwa T, Sato Y, Naoi M: Hydroxyl radical formation in diabeticrats induced by streptozotocin. Life Sci. 56: 1789–1798, 1995
Ronis M JJ, Huang J, Crouch J, Mercado C, Irby D, Valentin CR, Lumpkin CK, Ingelman—Sundberg M., Badger TM: Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two step mechanism associated with blood alcohol concentration in rats. J. Pharmacol. Exp. Ther. 264:944–950, 1993
Hong J, Pan J, Gonzalez FJ, Gelboin HV, Yang CS: The induction of a specific form of cytochrome P450 (P450j) by fasting. Biophys. Res. Commun.142: 1077–1083, 1987
Kimberley JW, Hafner MS, Novak RF: Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression.Hepatology 35: 263–273, 2002
Ingelman—Sundberg M, Johansson I, Hu Y, Tereliees Y, Eliasson E, Clot P, Albano E: Ethanol inducible cytochrome P450 2E1: Genetic polymorphism, regulation and possible role in the etiology of alcohol induced liverdisease. Alcohol 16: 447–452, 1993
French SW: Rationale for therapy for alcoholic liver disease.Gasteroenterology 109: 617–620, 1995
Roberts BJ, Shof SE, Jeong KS, Song BJ: Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration andwithdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 h or less. Biochem. Biophys. Res. Commun 205: 1064–1071, 1994
Warner M, Gustafsson JA: Effect of ethanol inducible cytochrome P450 in the rat brain. Proc. Natl. Acad. Sci. USA 91: 1019–1023, 1994
Tindberg N, Ingelman-Sundberg M: Expression, catalytic activity, and inducibility of cytochrome P450 2EI (CYP 2EI) in the rat central nervoussystem. J Neurochem 67: 2066–2073, 1996
Parmar D, Dayal M, Seth, PK: Expression of cytochrome P450s (P450s) in brain: Physiological, pharmacological and toxicological consequences.Proceedings of Indian National Academy of Sciences (PINSA—B) 6: 905–928, 2003
Anandatheerthavarada HK, Shankar SK, Bhamre S, Boyd MR, Song BJ, Ravindranath V: Induction of brain cytochrome P—450 IIE1 by chronic ethanoltreatment. Brain Res. 601: 279–785, 1993
Upadhya SC, Tirumalai PS, Boyd MR, Mori T, Ravindranath V: Cytochrome P4502E1 in brain: constitutive expression, induction by ethanol andlocalization by fluorescence in situ hybridization. Arch Biochem. Biophys 373: 23–34, 2000
Nissbrandt H, Bergquist F, Jonason J, Engberg G: Inhibition of cytochrome P4502E1 induces an increase in extracellular dopamine in ratsubstantia nigra: A new metabolic pathway? Synapse 40: 294–301, 2001
Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, Corsini GU: Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6—tetrahydropyridine—induced mouse model ofParkinson's disease. J Neurochem 91: 285–298, 2004
Streetman DS, Bertino JS Jr, Nafziger AN: Phenotyping of drug metabolizing enzymrs in adults: a review of in vivo cytochrome P450phenotyping probes. Pharmacogenetics 10: 187–216, 2000
Glowinski J, Iversen L L: Regional studies of catecholamines in the rat brain. I. The disposition of ‘H-norepinephrine, ‘H-dopamine and ’HDOPAin various regions of the brain. J Neurochem 13: 655–669, 1996
Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate — phenol chloroform extraction. Anal. Bichem 162:156–159, 1987
Soh Y, Rhee HM, Dong HS, Song BJ: Immunological detection CYP 2E1 in fresh rat lymphocytes and its pretranslational induction by fasting.Biochem and Biophys. Res. Commun. 227: 541–546, 1996
Castanguay A, Lin D, Stroner GD, Rook P, Furuya K. Hecht SS, Schul HAG, Klaunig JE: Comparative carcinogenenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'—nitrosonornlcodine, 4—(methylnitrosoamino)—1—(3—pyridyll)—1— butanonoe and their analogs. CancerRes. 43: 1223–1229, 1983
Hodgson AV, White TB, White JW, Strobel HW: Expression analysis of the mixed function oxidase system in rat brain by the polymerase chainreaction; Mol. Cell. Biochem. 120: 171–179, 1993
Lucas D, Berthou F, Dreano Y, Lozach P, Volant A, Menez JF: Comparison of levels of cytochrome P450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol Clin ExpRes. 17: 900–905, 1993
Medvedeva TN: A comparative study of the composition of the microsomal membranes of the liver, brain and skeletal muscles in vertebrates. Zh EvolBiokhim Fiziol 27: 694–700, 1991
Bourre JM: Roles of unsaturated fatty acids (especially omega—3 fattyacids) in the brain at various ages and during ageing. J Nutr Health Aging 8: 163–174, 2004
Howard LA, Miksys S, Hoffmann E, Mash D, Tyndale RF: Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol 138: 1376–1386,2003
Yoo JS, Ishizaki H, Yang CS: Enzyme kinetics of N—nitrosodimethylaminedemethylase in rodents and humans. IARC Sci Publ. 105: 366–369, 1991
Tu YY, Yang CS: High—affinity nitrosamine dealkylase system in rat livermicrosomes and its induction by fasting. Cancer Res. 43: 623–629, 1983
Reed CJ, Lock EA, and De Matteis F: Olfactory cytochrome P450; studieswith suicide substrates of the hemoprotein. J Biochem 253: 569–576, 1998
Irle E, Markowitsch HJ: Widespread neuroanatomical damage and learning deficits following chronic alcohol consumption or vitamin—B1(thiamine) deficiency in rats. Behav. Brain Res. 9: 277–294, 1983
Bellis MDD, Clark DB, Beers SR, Soloff PH, Boring AM, Hall J, Kersh A, Keshavan MS: Hippocampal volume in adolescent—onset alcohol usedisorders. Am. J. Psychiatry 157: 737–744, 2000
Laakso MP, Vaurio O, Savolainen L, Repo E, Soininen H, Aronen HJ, Tihonen J: A volume tri MRI study of the hippocampus in type 1 and 2alcoholism. Behav. Brain Res. 109: 177–186, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yadav, S., Dhawan, A., Singh, R.L. et al. Expression of constitutive and inducible cytochrome P450 2E1 in rat brain. Mol Cell Biochem 286, 171–180 (2006). https://doi.org/10.1007/s11010-005-9109-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9109-z